All News

Have you ever considered pursuing a PGY-2 pharmacy residency in critcal care?

The FDA has approved Newron Pharmaceutical’s Xadago (safinamide), an add-on treatment for patients with Parkinson’s disease.

Cardiac resynchronization therapy eligibility significantly decreased under new guidelines.

Prescription and over the counter non-steroidal anti-inflammatory drugs observed to increase the risk of cardiac arrest up to 50%.

Cancer-focused continuing education programs seek to enhance cancer care at specialty pharmacies.

Epic EHR system will be used among CVS Specialty Pharmacies.

Limiting carbohydrate intake could improve glycated hemoglobin levels.

Long-acting contraceptive observed to have a 1% failure rate.

Antibody therapy enables efficacious control of HIV-like virus in monkeys.

Need for an increase in HCV testing awareness among health care providers and baby boomers.

Investigational drug observed to induce synapse pruning in preclinical trials.

An estimated 86 million Americans have prediabetes, and 90% of them don't know they have it.

Physicians should test for more common liver conditions rather than rare diseases.

Several public health and antismoking groups are urging the FDA to enforce more stringent regulations on the manufacturing of tobacco products by banning candy and fruit-flavored e-cigarettes and cigars.

Researchers will investigate factors that may contribute to poor cancer outcomes among African Americans.

Study links anti-tumor immunity to islet autoimmunity.

Sixty-three percent of study participants developed both depression and dementia.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Metformin saves lives

Working in sales was so appealing to Brad that he decided to start his own business as a manufacturing representative.

States with expanded Medicaid had an increase in buprenorphine prescriptions.

Cannabis potency could be regulated to reduce side effects.

An interdisciplinary treatment modality is especially effective when treating patients with chronic pain.

The risk of a second cancer remained high even 30 years after treatment.

Progression-free survival with IMMU-132 increases from an average of 3.5 months to 16.6 months in patients with breast cancer.

Personalizing doses of warfarin through genetic testing helped reduce the risk of combined adverse events in patients undergoing elective orthopedic surgery, according to data presented at the American College of Cardiology's 66th Annual Scientific Session.

Association found between limited gluten intake and type 2 diabetes.

Novel investigational compound observed to treat chronic pain without side effects.

Patients who were prescribed a daily step goal increased their activity by 20%.